Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of Δ5-androstene-3β-ol-7,17-dione in the treatment of lupus erythematosus

Use of Δ5-androstene-3β-ol-7,17-dione in the treatment of lupus erythematosus

US Patent 6924274 · Granted Aug 2, 2005

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Diene and triene compounds and formulations2010
Diene compounds and formulations2009
Prostate cancer treatment2009
Steroids having 1,8-unsaturation and formulations comprising same2009
Prostate cancer treatment2008
Use of &Dgr;5-androstene-3&bgr;-OL7,17-dione in the treatment of arthritis2004
Process for effecting allylic oxidation2004
Use of &Dgr;5-androstene-3&bgr;ol-7,17-dione in the treatment of lupus erythemat2003
Use of &Dgr;5-androstene-3&bgr;ol-7,17-dione in the treatment of lupus erythemat2003
Stimulating transport of glucose into animal tissue by the administration of pin2003
Memory by the administration of &Dgr;5-androstene-3&bgr;-ol-7,17-dione and 3&bgr2002
Process for effecting allylic oxidation using dicarboxylic acid imides and chrom2002